Research shows that in senescent cells, p53 levels are maintained low through ubiquitination while its pro-apoptotic activity is repressed through nuclear segregation by FOXO4. The peptide's competitive inhibition restores p53 activity by promoting nuclear exclusion, allowing p53 to execute its pro-apoptotic program and eliminate senescent cells through targeted pathway activation
That shift, though, will likely take five or more years to materialize. As an industry, leaders note that we must develop innovative pricing models, value-based agreements, and strategies to ensure equitable access
Progesterone resistance helps explain why some treatments feel partial at best
Feel the difference in your skin the next morning
aim for at least 8 glasses daily
Domen PL, Muckerheide A, & Michael JG III (1987) Abrogation of oral tolerance